Glucagon-like insulinotropic peptides, compositions and methods
US5705483A · kind A · utility
117Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 1995 |
| Grant date | Jan 6, 1998 |
| Priority date | — |
| Expiry date | Mar 21, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/915
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel complexes consisting of certain GLP-1 molecules associated with a divalent metal cation that is capable of co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and methods of using such complexes for enhancing the expression of insulin in B-type islet cells is claimed, as is a method for treating maturity onset diabetes mellitus in mammals, particularly humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.